Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Accenture plc (ACN) vs Centene Corp (CNC) Price & Performance

Accenture plcTrade
Centene CorpTrade

Price performance (Past 24H)

Key statistics

Accenture plc vs Centene Corp — how do they compare? Accenture plc trades at $179.6 (market cap $109.08B), while Centene Corp trades at $65.66 (market cap $32.89B). The key difference: Accenture plc is far larger — about 3.3× Centene Corp's market cap, and Accenture plc pays a 3.66% dividend while Centene Corp pays none. Which is the better fit depends on your goals.

ACNCNC
Market Cap
$109.08B$32.89B
Sector
TechnologyHealth
52-Week High
$288.54$68.72
52-Week Low
$124.41$26.17
Enterprise Value
$107.30B$21.93B
Dividend Yield
3.66%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Accenture plc

Accenture (ACN) trades at $179.82, up 2.33% in the last session, with a bullish technical outlook and strong fundamental performance. The stock exhibits robust revenue growth, with 2025 revenue reaching $69.67 billion and net income of $7.68 billion, supported by consistent earnings beats. Recent partnerships with TEPCO Solution Advance and AlphaSense highlight strategic AI initiatives, enhancing its consulting and digital transformation services.

The investment outlook is positive, driven by solid financials, a consensus price target of $189.77, and low debt. Risks include competitive pressures and macroeconomic sensitivity. Analyst sentiment is strongly bullish with 66% buy ratings, indicating confidence in continued growth and shareholder value creation.

Centene Corp

Centene (CNC) trades at $65.77, up 2.48% with a bullish technical signal. Recent Q2 2026 earnings beat expectations with EPS of $2.51 versus $1.09 estimate, driven by margin recovery and cost control. Revenue grew to $194.78B in 2025, though net income was negative at -$6.67B. Valuation ratios are attractive with P/E of 8.06 and P/S of 0.16. Analyst consensus is strongly bullish with 61.37% buy ratings and a $70.36 price target.

Outlook is positive due to raised 2026 guidance and operational improvements, but risks include Medicaid membership softness and persistent negative margins. The stock offers value potential if profitability rebounds as projected, though investors should monitor medical cost trends and regulatory changes affecting government healthcare programs.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Accenture plc

Accenture PLC provides management and technology consulting services and solutions. The Company delivers a range of specialized capabilities and solutions to clients across all industries on a worldwide basis. Accenture operates a network of businesses provides consulting, technology, outsourcing, and alliances.

Read more on ACN

About Centene Corp

Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.

Read more on CNC